KDM2B and T-cell acute lymphoblastic leukemia: KDM2B is known to enhance terminally Th17 cell formation (69) and is involved in maintenance of T-cell acute lymphoblastic leukemia (70), which all could support the role of a phenotypic dysfunctional exhausted T cell type in the clusters without BACH2.